LORI WALTERS: Open Payments
NPI 1073219457 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 28 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $286 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $235 |
| Novo Nordisk Inc | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| ABBVIE INC. | 1 | $21 |
| Eisai Inc. | 1 | $17 |
| bioMerieux Inc | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
Products named: FARXIGA, AIRSUPRA, CAPLYTA, Ozempic, REXULTI, JARDIANCE, ZEPBOUND, VRAYLAR.
Industry payments across KS — which companies pay providers there.
